drugset / Trial / NCT00312182

Thorough QT Study of Nelfinavir

NCT00312182

Phase 4 Completed 68 enrolled Pfizer
RandomizedCrossoverDouble-blindTreatment

Summary

To assess if nelfinavir has any clinically meaninful effect on cardiac function, namely ECG evaluation

Timeline

Start
2006-03
Primary completion
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Nelfinavir Other / unclassified

Indications

No indication recorded.